4//SEC Filing
MANCINI ALEXANDRA DIANE JANET 4
Accession 0001213900-22-072918
CIK 0001728328other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 7:37 PM ET
Size
5.9 KB
Accession
0001213900-22-072918
Insider Transaction Report
Form 4
MANCINI ALEXANDRA DIANE JANET
Sr VP, Clinical/Reg Affairs
Transactions
- Award
Employee Stock Option (Right to Buy)
2022-11-14+4,200→ 8,152 totalExercise: $2.78Exp: 2027-11-13→ Common shares (4,200 underlying)
Footnotes (2)
- [F1]The options were granted on 11/14/2022 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant.
- [F2]On September 7, 2022, the common stock of InMed was reverse split on a 1-for-25 basis. This number reflects that reverse stock split.
Documents
Issuer
InMed Pharmaceuticals Inc.
CIK 0001728328
Entity typeother
Related Parties
1- filerCIK 0001817890
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 7:37 PM ET
- Size
- 5.9 KB